Team member

COO

Medical Device

Peter Roldskov Pedersen

Reviewing and approving laboratory SOPs. Develop, direct, and implement field investigations. Setting operation budget including capital equipment forecast forward, a new normal that has evolved from generation.

PHONE NUMBER

+45 60134063

EMAIL ADDRESS

peter.roldskov@aptiogroup.com

COO

Medical Device

Peter Roldskov Pedersen

Laboratory analysis may be carried out for a number of reasons – usually linked to ensuring a product has been manufactured to meet specifications and regulations and is safe to be released to the market place.
It is imperative then, that the results of the analysis can be trusted, in terms of their accuracy and reproducibility. For a number of reasons – usually linked to ensuring a product has been manufactured to meet specifications.

COO

Medical Device

Peter Roldskov Pedersen

He has developed essays in the following areas: UPLC-MS/MS, GC-FID, in vivo microdialysis, HPLC-(UV, fluorescence, electrochemical), 2D-gel electrophoresis.

Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline.

Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits.

Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive.

Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.

Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI.

Contact

CEO & President
Aptio Group
Vice President
Quality & Compliance
Managing Partner
Engineering I